iShares U.s. Healthcare ETF (IYH): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders of IYH (all 13F filers)
- UBS Group2.6 MBank or trading desk+52 K
- Morgan Stanley2.2 MBank or trading desk−25 K
- Bank of America1.5 MBank or trading desk−2,207
- LPL Financial1.5 MWealth adviser+70 K
- PGIM Custom Harvest1.1 MType not verified−14 K
- Northwestern Mutual Wealth Management1.0 MWealth adviser+26 K
- Wells Fargo915 KBank or trading desk−132 K
- Royal Bank of Canada850 KBank or trading desk−50 K
- Raymond James Financial756 KWealth adviser+85 K
- Oakworth Capital610 KType not verified+192 K
- Shares
- 2.6 M
- Change
- +52 K
See more
- Type
- Bank or trading desk
- Value
- $173M
- Shares
- 2.2 M
- Change
- −25 K
See more
- Type
- Bank or trading desk
- Value
- $148M
- Shares
- 1.5 M
- Change
- −2,207
See more
- Type
- Bank or trading desk
- Value
- $102M
- Shares
- 1.5 M
- Change
- +70 K
See more
- Type
- Wealth adviser
- Value
- $99.3M
- Shares
- 1.1 M
- Change
- −14 K
See more
- Type
- Type not verified
- Value
- $70.7M
- Shares
- 1.0 M
- Change
- +26 K
See more
- Type
- Wealth adviser
- Value
- $69.0M
- Shares
- 915 K
- Change
- −132 K
See more
- Type
- Bank or trading desk
- Value
- $61.3M
- Shares
- 850 K
- Change
- −50 K
See more
- Type
- Bank or trading desk
- Value
- $56.9M
- Shares
- 756 K
- Change
- +85 K
See more
- Type
- Wealth adviser
- Value
- $50.7M
- Shares
- 610 K
- Change
- +192 K
See more
- Type
- Type not verified
- Value
- $41.0M
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.
This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.
Above 5% over time (13D/13G)
Each holder with its filings in order. History since December 2024.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗